实验性气体等离子体疗法治疗乳腺癌中的免疫刺激作用。

Immunostimulation in experimental gas plasma therapy for breast cancer.

作者信息

Bekeschus Sander

机构信息

ZIK plasmatis, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Strasse 2, 17489 Greifswald, Germany; Comprehensive Cancer Center Mecklenburg-Vorpommern (CCC-MV), Department of ZIK plasmatis (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany; Leibniz Research Network Immune-mediated Diseases, Department of ZIK plasmatis (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany; Leibniz Research Alliance Health Technologies, Department of ZIK plasmatis (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany.

出版信息

Trends Biotechnol. 2022 Sep;40(9):1021-1024. doi: 10.1016/j.tibtech.2022.06.007. Epub 2022 Jul 11.

DOI:10.1016/j.tibtech.2022.06.007

PMID:35831219

Abstract

Gas plasma is a partially ionized gas operated at body temperature, expelling various reactive oxygen species (ROS) in chorus. While the technology's anticancer potential is generally appreciated, exciting progress in experimental gas plasma therapy for breast cancer has been made recently, particularly in empowering anticancer immunity.

摘要

气体等离子体是一种在体温下运行的部分电离气体，能同时释放多种活性氧（ROS）。虽然该技术的抗癌潜力已得到普遍认可，但最近在乳腺癌实验性气体等离子体治疗方面取得了令人兴奋的进展，尤其是在增强抗癌免疫力方面。